Inferra AI / Company / OPCH

Option Care Health, Inc.

OPCH · Health Care

Last earnings Jul 29, 2026

Key results

Net revenuequarter

$1,416.1 million

Net revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Growthquarter

up 15.4%

Net revenue of $1,416.1 million, up 15.4% compared to $1,227.2 million in the second quarter of 2024

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Gross profit of $269.0 million, or 19.0% of net revenue, up 7.9% compared to $249.4 million, or 20.3% of net revenue, in the second quarter of 2024

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Net incomequarter

$50.5 million

Net income of $50.5 million, compared to

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

net income of $53.0 million, in the second quarter of 2024 and diluted

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

EPSquarter

$0.31

earnings per share of $0.31, up 3.3% compared to diluted

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

earnings per share of $0.30 in the second quarter of 2024

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Adjusted net incomequarter

$67.5 million

Adjusted net income of $67.5 million, compared to adjusted

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

net income of $64.9 million, in the second quarter of 2024 and adjusted diluted

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

AI analysis

Q2 2025 · reported Jul 30, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Net revenue · Q2 2025
$1,416.1M
+15.4% +$189M vs year ago computed from stated figures
EX-99 · Jul 30, 2025
EPS · Q2 2025
$0.31
EX-99 · Jul 30, 2025
Net income · Q2 2025
$50.5M
EX-99 · Jul 30, 2025
Adjusted net income · Q2 2025
$67.5M
EX-99 · Jul 30, 2025

The quarter in charts

Revenue — quarterly

As stated

00.511.5$1,227.2MSame quarter last year$1,416.1MQ2 2025

EX-99 · Jul 30, 2025 Statement values as stated in the release.

Guidance ladder — revenue

Delivered vs the company's guided range

EX-99 · Jul 30, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.

Headline figures

MetricQ2 2025Prior qtrYear ago
Net revenue$1,416.1 million—$1,227.2 million
Growthup 15.4%——
Net income$50.5 million——
EPS$0.31——
Adjusted net income$67.5 million——

EX-99 · Jul 30, 2025

Guidance · company-stated

Net revenue$5.50 billion
Adjusted diluted earnings per share

“of $1.65 to $1.72”

Adjusted EBITDA

“of $465 million to $475 million”

Effective tax rate

“of 25%”

Midpoint vs latest-quarter revenue+288.4%computed from stated figures

Guidance stated in the release's Business Outlook table for the full year 2025; no direction stated — figures as stated in the table.

Next earningsNo verified date on fileNo date is estimated or imported

Capital allocation

As defined by the Company (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted.

The interest rate on the Company s term loan (the First Lien Term Loan ) was 5.37 % and 5.67 % as of June 30, 2026 and December 31, 2025, respectively.

What changed vs last quarter

  • Guide midpoint vs latest-quarter revenue +288.4% computed from stated figures
General educational research only — not investment advice.Every figure is as stated in the held documents; values marked “computed from stated figures” are arithmetic on those stated figures. Guidance shown is the company’s own stated guidance. No price targets, no recommendations, no consensus estimates.

Event summary

OPTION CARE HEALTH ANNOUNCES FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025

Based on: Earnings release + parent 8-K + 10-Q — transcript not held

Guidance & outlook

Net revenue: “Net revenue of $5.50 billion to $5.65 billion”

Adjusted diluted earnings per share: “Adjusted diluted earnings per share of $1.65 to $1.72”

Adjusted EBITDA: “Adjusted EBITDA of $465 million to $475 million”

Effective tax rate: “Effective tax rate of 25%”

Net revenue (“the full year 2025”)
“Net revenue of $5.50 billion to $5.65 billion”

Adjusted diluted earnings per share (“the full year 2025”)
“Adjusted diluted earnings per share of $1.65 to $1.72”

Adjusted EBITDA (“the full year 2025”)
“Adjusted EBITDA of $465 million to $475 million”

Effective tax rate (“the full year 2025”)
“Effective tax rate of 25%”

Guidance stated in the release's Business Outlook table for the full year 2025; no direction stated — figures as stated in the table.

Capital allocation

As defined by the Company (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

The interest rate on the Company s term loan (the First Lien Term Loan ) was 5.37 % and 5.67 % as of June 30, 2026 and December 31, 2025, respectively.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

The weighted average interest rate incurred on the First Lien Term Loan was 5.40 % and 5.42 % for the three and six months ended June 30, 2026, respectively.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

The weighted average interest rate incurred on the First Lien Term Loan was 6.57 % and 6.58 % for the three and six months ended June 30, 2025, respectively.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

The First Lien Term Loan matures on September 22, 2032.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

As of June 30, 2026, the Company had $ 4.0 million of undrawn letters of credit issued and outstanding, resulting in net borrowing availability under the Revolver Facility of $ 846.0 million.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

Strategy & priorities

Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Instead, they are based only on the Company s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

Use of derivative financial instruments in hedging strategies subjects the Company to certain risks, such as market and credit risks.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

The hierarchy places the highest priority on unadjusted quoted market prices in active markets for identical assets or liabilities (Level 1 measurements) and gives the lowest priority to unobservable inputs (Level 3 measurements).

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

Risks & headwinds

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following changes in laws and regulations applicable to our business model changes in market conditions and receptivity to our services and offerings pending and future litigation potential liability for claims not covered by insurance and loss of relationships with managed care organizations and other non-governmental third party payers.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

We have not reconciled Adjusted EBITDA or Adjusted diluted earnings per share guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items.

SEC original ↗Option Care Health, Inc. — Earnings release (8-K exhibit)EX-99Jul 30, 2025

Legal Proceedings 35 Item 1A.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company s control.

SEC original ↗Option Care Health, Inc. — 10-Q Quarterly report10-QJul 29, 2026

Documents

Earnings deck slides

0 decks with slide view

Option Care Health, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Option Care Health, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Option Care Health, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Option Care Health, Inc. — Presentation / slide deck (8-K exhibit) — Slide view unavailable — this deck was filed as a web document, whose text has no page boundaries.

Competitors

Competitors & peers

Same GICS sector — classification peers, not declared competitors

Filings

30 documents

Earnings releases

12 documents

Presentations

4 documents

Transcripts

0 documents

No transcripts for Option Care Health, Inc. are held in this edition of the library.

Mentioned by

1 company

Other tracked companies whose held documents mention Option Care Health, Inc. by name or ticker. A mention is counted once per document, from the document text the library holds.

See also the earnings calendar for every tracked company’s next earnings date.